Loading…
Johnson & Johnson is projected to rise to $294.99 by 2027, a +28% move from its current price of $231.29. JNJ is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $229.20 | $231.38 | $233.58 | +0.04% |
| May 30 | $228.39 | $231.47 | $234.59 | +0.08% |
| May 31 | $227.79 | $231.56 | $235.39 | +0.11% |
| Jun 1 | $227.30 | $231.64 | $236.08 | +0.15% |
| Jun 2 | $226.88 | $231.73 | $236.70 | +0.19% |
| Jun 3 | $226.50 | $231.82 | $237.27 | +0.23% |
| Jun 4 | $226.17 | $231.91 | $237.80 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $226.17 | $231.91 | $237.80 | +0.27% |
| Week 2 | $224.43 | $232.53 | $240.92 | +0.54% |
| Week 3 | $223.25 | $233.16 | $243.50 | +0.81% |
| Week 4 | $222.35 | $233.78 | $245.80 | +1.08% |
| Week 5 | $221.63 | $234.41 | $247.92 | +1.35% |
| Week 6 | $221.04 | $235.04 | $249.92 | +1.62% |
| Week 7 | $220.55 | $235.67 | $251.83 | +1.89% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech, with products spanning oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism for prescription use, as well as a MedTech portfolio used in surgery, orthopedic, cardiovascular, and vision fields and associated technologies.
The company was founded in 1886 and is based in New Brunswick, New Jersey.
Johnson & Johnson launched on January 1, 1886.
Johnson & Johnson is a healthcare company trading under the symbol JNJ. It currently sits at $234.34 per share with a market cap of $564.11B and a rank of 20. The near-term technical picture is bullish, with RSI at 60 and price near the 50-day simple moving average of $233.36, above the 200-day moving average of $210.74.
Near-term support sits at $221.32 and resistance at $240.10, with a 30-day price range of $220.50 to $249.05. The longer-range forecast suggests meaningful upside beyond the near term, with the 2026 average price at $234.34 and expanding through 2030 and beyond, culminating in a 2050 average of $2,306.30 and a 884.2% ROI.
A major floor 7.9% below — a decisive break under it would weaken the trend.
The nearest floor, 4.3% below — buyers have tended to step in here.
The nearest ceiling, 3.2% above — a clean break opens room to run.
A major ceiling 7.5% above — clearing it would confirm fresh momentum.
Key JNJ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of JNJ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $231.37 | Sell | $231.04 | Buy |
| MA 10 | $230.37 | Buy | $230.02 | Buy |
| MA 20 | $227.60 | Buy | $229.50 | Buy |
| MA 50 | $232.90 | Sell | $230.95 | Buy |
| MA 100 | $232.28 | Sell | $227.04 | Buy |
| MA 200 | $211.33 | Buy | $213.43 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.43 | Neutral |
| Stoch RSI (14) | 76.94 | Neutral |
| CCI (20) | 79.74 | Neutral |
| Williams %R (14) | -23.43 | Info |
| MACD (12,26,9) | 1.06 | Buy |
| ROC (12) | 4.50 | Buy |
| Bollinger %B (20,2) | 0.76 | Neutral |
| Stochastic %K (14) | 76.57 | Neutral |
| TRIX (15) | -0.09 | Sell |
| Awesome (5,34) | 1.62 | Buy |
| Ultimate (7,14,28) | 61.87 | Neutral |
| Momentum (10) | 7.03 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 232.62 | Sell |
| ADX (14) | 14.29 | Neutral |
| ATR (14) | 2.18 | Info |
The 30-day technical picture is bullish, with RSI14 at 60 signaling upward momentum. The price is hovering around the 50-day moving average of $233.36, in contrast to the 200-day moving average of $210.74, which supports a constructive setup.
Support is indicated at $221.32 and resistance at $240.10, with the 30-day trading range between $220.50 and $249.05.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $204.31 | $231.29 | $302.94 | 0% | Neutral | |
| $240.99 | $294.99 | $377.97 | +28% | Bullish | |
| $280.10 | $349.13 | $459.03 | +51% | Bullish | |
| $324.10 | $410.09 | $550.40 | +77% | Bullish | |
| $360.94 | $462.79 | $632.11 | +100% | Bullish | |
| $369.33 | $479.27 | $664.82 | +107% | Bullish | |
| $392.96 | $515.63 | $725.32 | +123% | Bullish | |
| $433.81 | $575.20 | $819.48 | +149% | Bullish | |
| $505.33 | $676.64 | $975.42 | +193% | Bullish | |
| $569.87 | $770.24 | $1,122.61 | +233% | Bullish | |
| $775.38 | $1,092.89 | $1,668.75 | +373% | Bullish | |
| $1,390.85 | $2,102.15 | $3,439.68 | +809% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $204.31 | $231.29 | $270.73 | +0.00% |
| June 2026 | $202.63 | $236.37 | $281.09 | +2.20% |
| July 2026 | $204.13 | $239.51 | $287.51 | +1.33% |
| August 2026 | $201.13 | $237.05 | $286.63 | -1.03% |
| September 2026 | $202.96 | $240.09 | $292.03 | +1.28% |
| October 2026 | $208.85 | $247.90 | $303.16 | +3.25% |
| November 2026 | $208.57 | $248.31 | $305.09 | +0.16% |
| December 2026 | $205.59 | $245.47 | $302.94 | -1.14% |
Click any year to see its month-by-month JNJ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Johnson & Johnson's 2026 outlook centres on $231.29, within a $204.31 to $302.94 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, JNJ could reach as high as $377.97, with a base case around $294.99 and support toward $240.99 — roughly +28% from $231.29. Momentum favours further upside here.
Expect JNJ to range from $280.10 to $459.03 through 2028. The $349.13 average target implies a +51% move from current prices. That is up +18% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The JNJ price prediction for 2029 points to an average of $410.09 (low $324.10, high $550.40) — a potential gain of +77% on today's $231.29. Momentum favours further upside here.
In 2030, JNJ is projected to trade between $360.94 and $632.11, averaging $462.79 — a potential gain of +100% from today's $231.29. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Johnson & Johnson's 2031 outlook centres on $479.27, within a $369.33 to $664.82 range. That is up +4% on the projected 2030 average. That marks a +107% change versus current levels. Momentum favours further upside here.
By 2032, JNJ could reach as high as $725.32, with a base case around $515.63 and support toward $392.96 — roughly +123% from $231.29. Buyers look set to stay in control over this stretch.
Expect JNJ to range from $433.81 to $819.48 through 2033. The $575.20 average target implies a +149% move from current prices. That is up +12% on the projected 2032 average. Momentum favours further upside here.
The JNJ price prediction for 2034 points to an average of $676.64 (low $505.33, high $975.42) — a potential gain of +193% on today's $231.29. Buyers look set to stay in control over this stretch.
In 2035, JNJ is projected to trade between $569.87 and $1,122.61, averaging $770.24 — a potential gain of +233% from today's $231.29. That is up +14% on the projected 2034 average. Momentum favours further upside here.
Johnson & Johnson's 2040 outlook centres on $1,092.89, within a $775.38 to $1,668.75 range. That is up +42% on the projected 2035 average. That marks a +373% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, JNJ could reach as high as $3,439.68, with a base case around $2,102.15 and support toward $1,390.85 — roughly +809% from $231.29. Momentum favours further upside here.
Investing $1,000 in JNJ today (≈ 4.323576 JNJ) could be worth
$9,088.8
+$8,088.8 (+809%) by 2050 · US Dollar
Based on the average projected JNJ price of $2,102.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in JNJwould be worth at today's price.
$1,000 invested in JNJ on May 27, 2025 (≈ 6.525285 JNJ) would be worth
$1,509.23
+$509.23 (+50.9%) today · 1.51× · US Dollar
Based on a JNJ entry price of $153.25 vs. today's $231.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $229.32 | $1,008.59 | +0.9% |
| 1 month ago | $225.34 | $1,026.4 | +2.6% |
| 3 months ago | $243.47 | $949.97 | -5.0% |
| 6 months ago | $206.92 | $1,117.77 | +11.8% |
| 1 year ago | $153.25 | $1,509.23 | +50.9% |
| All time (5.0y) ago | $165.53 | $1,397.27 | +39.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our JNJ forecast.
Our base-case forecast reaches $460.00 around 2030.
Implied market cap at $460.00: $1.11T
The multi-year forecast shows a gradual, then accelerating, upside. The 2026 average is $234.34 with a 0% ROI and neutral sentiment. From 2027 onward, the outlook turns bullish, with 2027 avg $305.18 and ROI 30.2%, 2028 avg $362.30 and ROI 54.6%, 2029 avg $428.09 and ROI 82.7%, and 2030 avg $486.61 with ROI 107.7%.
By 2040 the forecast envisions an avg of $1,187.42 and ROI 406.7%, and by 2050 an avg of $2,306.30 with ROI 884.2%.
These figures illustrate substantial potential upside, but they are estimates, not guarantees, and actual results can differ due to market conditions and other factors.
Tap a question to reveal the answer.
2030 avg $486.61, min $379.46, max $664.80, ROI 107.7, sentiment BULLISH.
Current price $234.34; market cap $564.11B.
Yes. The 2026 forecast is neutral with avg $234.34, and from 2027 onward the outlook is bullish (e.g., 2027 avg $305.18, ROI 30.2%, 2028 avg $362.30, ROI 54.6%, 2029 avg $428.09, ROI 82.7%, 2030 avg $486.61, ROI 107.7%).
RSI14 60; SMA50 $233.36; SMA200 $210.74; support $221.32; resistance $240.10; thirty-day range $220.50-$249.05.
2050 min $1,525.79; avg $2,306.30; max $3,774.04; ROI 884.2; sentiment BULLISH.
Johnson & Johnson Community Discussion
0Share your Johnson & Johnson price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.